Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370651 · ClinicalTrials.gov registry record · NA
Emsella Chair vs Sham for Male Sexual Dysfunction
A NA study of Ejaculatory Dysfunction and Male Sexual Dysfunction, sponsored by Corewell Health East.
- Recruiting
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT05370651 is a NA study of Ejaculatory Dysfunction and Male Sexual Dysfunction that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 117 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05370651, a NA study of Ejaculatory Dysfunction and Male Sexual Dysfunction, is actively recruiting participants, sponsored by Corewell Health East.
- RECRUITING
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
We will be performing this study in 2 phases: Phase 1 will be an open label pilot study of 10 male participants. All participants in the pilot study will receive active treatment. If data from the pilot study is suggestive of symptom improvement, we will continue on to phase 2, which is a sham controlled, randomized blinded study. Participants in phase 2 will be randomized to receive either active treatment or sham. Potentially a total of 117 participants for both phases will be enrolled. The purpose of this study is to compare the Emsella Chair to sham and to determine whether electromagnetic technology is effective in the treatment of sexual dysfunction, specifically erectile dysfunction (EjD) in men.
Conditions Studied
Interventions
- DEVICE BTL Emsella Chair
Study Locations (1)
Michigan
- Corewell Health William Beaumont University Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2022-12-14 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05370651
The ClinicalTrials.gov registry entry for NCT05370651 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ejaculatory Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which BTL Emsella Chair is the first listed.
NCT05370651 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05370651 about?
NCT05370651 is a clinical study titled "Emsella Chair vs Sham for Male Sexual Dysfunction". We will be performing this study in 2 phases: Phase 1 will be an open label pilot study of 10 male participants. All participants in the pilot study will receive active treatment. If data from the pilot study is suggestive of symptom improvement, we will continue on to phase 2, which is a sham contr...
What is the current status of trial NCT05370651?
This trial is currently recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2022-12-14. Estimated completion is 2027-12.
What conditions does trial NCT05370651 study?
This clinical trial studies the following conditions: Ejaculatory Dysfunction, Male Sexual Dysfunction.
What interventions are being tested in trial NCT05370651?
The interventions under investigation include: BTL Emsella Chair (DEVICE).
Who is sponsoring clinical trial NCT05370651?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05370651 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ejaculatory Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.